MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES

Size: px
Start display at page:

Download "MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES"

Transcription

1 MANAGEMENT OF THE BLADDER IN THE POSTOPERATIVE PERIOD FOLLOWING UNCOMPLICATED GYNAECOLOGICAL SURGERY CLINICAL GUIDELINES 1. Aim/Purpose of this Guideline All clinical staff working in the Division of women, children & sexual health to provide evidence based guidance in the management of the bladder in the postoperative period following uncomplicated gynaecological surgery 2. The Guidance Background: There is little consensus in the literature of the best management of the bladder in the immediate postoperative period following uncomplicated gynaecological surgery. Women in the immediate postoperative period following gynaecological surgery have a high incidence of urinary retention Urethral catheters are commonly used following gynaecological surgery Indwelling catheters are associated with increased risks of urinary tract infection (UTI) and the longer they are in situ, the higher the risk of UTI Guideline for removal of catheter: The planned date of removal of catheter should be clearly stated on the operation note / in the medical notes. All urethral catheters are removed at on the scheduled day of removal, unless otherwise stated in the medical notes Attached is the voiding protocol and post op bladder diary. The amounts voided and bladder scan residual volumes should be recorded on a bladder diary and dated and signed by the nurse performing the check. This record should be at the patient s bedside at all times. While awaiting woman to empty her bladder, she should be encouraged to drink normal amount of fluids and try to empty her bladder by going to the toilet / having a bath / shower etc. Possible reasons for being unable to pass urine / empty bladder completely: 1. Bruising / swelling around bladder / urethra especially following anterior vaginal wall repair this will usually improve over 1-2 weeks Page 1 of 10

2 2. Overdistension of the bladder resulting in atonic bladder (acute / chronic) 3. Poor urinary flow rates prior to surgery (may have been detected on urodynamics) 4. Physical obstruction (eg midurethral sling / sutures) Suspect if unable to pass urine at all post op speak to consultant in charge 5. Clot retention suspect if a history of haematuria NOTE for complex laparoscopic surgery for severe endometriosis: Patients who fail their primary TWOC, need to be discharged with an indwelling catheter for one week and repeat TWOC on return. If they fail a second time it should be discussed with a member of the endometriosis team Guidelines for women sent home with an indwelling catheter Ensure can empty catheter bag herself and understands catheter care (instructed by nursing staff on ward) Ensure has ward number on the discharge letter to call in an emergency Ensure has follow up appointment for TWOC usually in EGU There should be no need for prophylactic antibiotics unless patient symptomatic of a urinary tract infection. Guidelines for women returning for Trial without catheter (TWOC) Ward staff to discuss the option/process of catheter removal at home on the day of TWOC to save waiting time in the hospital after catheter removal which may be up to 4 hours. Those patients who can remove catheters at home, get a bladder scan in EGU to measure residual volume in bladder following her void. Patients who cannot remove catheters at home are seen early in the morning in EGU e.g and 0910 slots (or Gynaecology ward if EGU closed). The catheter is removed and the patient sent away with instructions to drink as normal (or at least 1 litre of water over the next few hours). She may leave the hospital and indeed is encouraged to, in order to relieve any anxiety that may be present by being in hospital The patient is advised to attempt to void when she has the desire and to return to EGU at an allotted time (usually after 6 hours and by that time, most women would have voided twice) for a scan to measure post void bladder residual volume* If she is unable to void at all / becomes anxious / distressed / is in pain, she should return to EGU earlier and follow the voiding protocol attached. If patient is sent home with an indwelling catheter following a midurethral sling procedure, inform the surgeon who performed the operation (early division of the tape may be considered) If patient voids >150ml and the post void residual is <150mls, reassure woman and Page 2 of 10

3 discharge (complete discharge letter) Patients with unsuccessful trial in EGU, who would be offered ISC, arrange a time / place to teach ISC and use the starter packs available in EGU / Gynaecology ward. Before patient discharged home performing CISC, ensure has follow up arranged with the Bladder & Bowel Specialist Service by written referral and sending to via Groupwise to Enquiries.ContinencePromotion@Cornwall.NHS.UK Bladder scan for post void residual check: This may be done using a specific bladder scanner (located on Gynaecology ward) or using the USS machine in EGU (use the abdominal probe, select menu and scroll down to bladder volume ) ISC Instruction The aim is to train as many of the gynaecology nurses to be able to teach CISC as possible. This is to be done in conjunction with Sharon Eustice (nurse continence consultant) using the same methods and same kit to ensure continuity If there is no one on duty who is trained to teach CISC, then contact the Bladder & Bowel Specialist Service to ask for their help via (please note: the team are not able to teach CISC immediately). See flow chart below: Page 3 of 10

4 VOIDING PROTOCOL FOLLOWING BENIGN GYNAECOLOGY OPERATION Catheter removal time should be recorded on the fluid volume chart and on the bladder diary - Encourage to drink normal amounts of mixed fluids - Women should be encouraged to try to void if haven t already at 4hours following catheter removal/after surgery. - Measure the voided volume on second void and measure residual volume by bladder ultrasound scan soon after the void. (no later than 6hours from catheter removal/postop if coming out of theatre without catheter, with a normal fluid intake) - Residual volume to be measured immediately after the patient passes urine per urethra (see Note below about Endometriosis Patients) - If uncomfortable & unable to pass urine before the 4 hrs interval, check residual by scan and follow protocol as below On 2 nd void, voided more than 150 ml with residual between 150 and 400 ml Void more than 150 mls with residual less than 150mls x once Void less than 150 ml with residual more than 400 ml x 2 nd void Rpt void and residual check every 2 hrs Insert Foley catheter No 12 with Flip flo valve and leave in situ No futher checks needed, unless unless the woman feels she is unable to completely void subsequently At discharge: - Foley s catheter in situ with flip flo valve for daytime and leg bag for night - Flip flo valve to be released every 4 hrs during day and leg bag on free drainage during night - Book trial without catheter in emergency gynaecology unit (EGU) in 5-7 days - Ward staff to discuss with the patient the option and process of catheter removal at home (if possible) on the day of TWOC prior to coming to EGU. - If TWOC is unsuccessful again in EGU, arrangements to be made for the patient to learn intermittent self catheterisation (ISC) * NOTE for complex laparoscopic surgery for severe endometriosis: Patients who have more than 150mls in the bladder at their first TWOC, need to be discharged with an indwelling catheter for one week and repeat TWOC on return. Do Not follow the algorithm above for these patients. If they fail TWOC a week later (more than 150mls) it should be discussed with a member of the endometriosis team Page 4 of 10

5 POSTOPERATIVE BLADDER DIARY Name: Hospital Number: Date: Time Volume of urine passed per urethra Residual urine by bladder scan Volume of urine drained via catheter Name of nurse Instructions 1. Use this chart in conjunction with the flow-chart for voiding protocol for Urogynaecology patients) 2. Insert time in column one for each event 3. If a catheter is inserted please document the time of insertion and time of measurement of urinary volume drained (usually 20 minutes or until catheter stops draining) 4. If there are any concerns regarding management contact the operating surgeon/ on call via the switchboard. Page 5 of 10

6 3. Monitoring compliance and effectiveness Element to be monitored Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Audit the compliance to guideline and the voiding protocol Miss Farah Lone, Consultant O&G Ad hoc monitoring of guidance as part of routine audit activity Biannual review presented at the Audit and Governance meeting Audit and Governance meeting Audit and Governance meeting Required changes to practice will be identified and actioned within 3 months. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders 4. Equality and Diversity 4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 6 of 10

7 Appendix 1. Governance Information Document Title Management of the Bladder in the postoperative period following uncomplicated gynaecological surgery Date Issued/Approved: 11/04/2017 Date Valid From: 08/06/2017 Date Valid To: 08/06/2020 Directorate / Department responsible (author/owner): Miss Farah Lone Consultant O&G Contact details: Brief summary of contents Suggested Keywords: Target Audience Executive Director responsible for Policy: All clinical staff working in the Division of women, children & sexual health to provide evidence based guidance in the management of the bladder in the postoperative period following uncomplicated benign gynaecological surgery Post operative, Voiding, Gynaecology, Bladder care RCHT PCH CFT KCCG Medical Director Date revised: 11/04/2017 This document replaces (exact title of previous version): Management of the Bladder in the postoperative period following uncomplicated gynaecological surgery Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Name and Post Title of additional signatories Signature of Executive Director giving approval Publication Location (refer to Policy on Policies Approvals and Obstetric & Gynaecology Directorate meeting Medical Director Not Required {Original Copy Signed} Internet & Intranet Intranet Only Page 7 of 10

8 Ratification): Document Library Folder/Sub Folder Links to key external standards Related Documents: Training Need Identified? Clinical / Gynaecology Governance Team can advise Reference and Associated documents No Version Control Table Date Versi on No Summary of Changes Changes Made by (Name and Job Title) 13 Jun 14 V1.0 Initial Issue 11/04/2017 V1.1 Minor changes Lee Azancot Data Administrator Farah Lone Consultant All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 8 of 10

9 Appendix 2. Initial Equality Impact Assessment Form Name of Name of the strategy / policy /proposal / service function to be assessed (hereafter referred to as policy) (Provide brief description): Voiding Protocol Following Benign Gynaecology Operation Directorate and service area: Is this a new or existing Policy? Gynaecology Existing Name of individual completing Telephone: assessment: Miss Farah Lone 1. Policy Aim* Who is the strategy / policy / proposal / service function aimed at? 2. Policy Objectives* As above All clinical staff working in the Division of women, children & sexual health to provide evidence based guidance in the management of the bladder in the postoperative period following uncomplicated gynaecological surgery 3. Policy intended Outcomes* 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a) Is consultation required with the workforce, equality groups, local interest groups etc. around this policy? As above See section 3 All obs & benign gynae patients No b) If yes, have these *groups been consulted? C). Please list any groups who have been consulted about this procedure. 7. The Impact Please complete the following table. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Rationale for Assessment / Existing Evidence Age Page 9 of 10

10 Sex (male, female, transgender / gender reassignment) Race / Ethnic communities /groups Disability - learning disability, physical disability, sensory impairment and mental health problems Religion / other beliefs Marriage and civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major service redesign or development 8. Please indicate if a full equality analysis is recommended. Yes No x 9. If you are not recommending a Full Impact assessment please explain why. Signature of policy developer / lead manager / director Date of completion and submission Names and signatures of members carrying out the Screening Assessment 1. Miss Farah Lone 2. Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead, c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD A summary of the results will be published on the Trust s web site. Signed Date Page 10 of 10

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018

Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0. March 2018 Blood Glucose and Hyperglycaemia Management in Hospital for Adults with Diabetes Clinical Guideline V2.0 March 2018 Page 1 of 8 Summary flow chart for monitoring of blood glucose if >11mmol/L For Adults

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF NEBULISED PENTAMIDINE Summary. 1. Patient requires nebulised Pentamidine Ensure equipment listed is available Ensure HEPA filtered room in Haematology Clinic

More information

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol

Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol Clinical Guideline for Intravenous Opioids for Adults in Recovery Areas The Recovery Protocol 1. Aim/Purpose of this Guideline 1.1. To Provide safe and efficient administration of Opioids in Recovery.

More information

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist

28 th September Author Jeremy Gilbert Bariatric Nurse Specialist POLICY FOR SELF ADMINISTRATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE BY COMPETENT PATIENTS COMING IN FOR METABOLIC AND OBESITY SURGERY (BARIATRIC SURGERY) TO PENDENNIS WARD 28 th September 2014 Author

More information

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary.

CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. CLINICAL GUIDELINE FOR THE ADMINISTRATION OF MESNA WITH IFOSFAMIDE AND CYCLOPHOSPHAMIDE Summary. Yes Is patient prescribed ifosfamide or cyclophosphamide >1g/m 2? Chemotherapy prescription on Aria should

More information

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline

SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline SALBUTAMOL INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department

More information

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance

HYPOSPADIAS NEONATAL CLINICAL GUIDELINE. 1. Aim/Purpose of this Guideline. 2. The Guidance HYPOSPADIAS NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all staff managing the initial care of infants born with hypospadias. It includes assessment and

More information

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0

DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 DIAGNOSIS AND MANAGEMENT OF PYLORIC STENOSIS IN CHILDREN CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline This guideline is relevant to all medical and nursing staff caring for children with Pyloric

More information

School Hearing Screening Policy

School Hearing Screening Policy School Hearing Screening Policy V2.1 1st August 2017 Page 1 of 13 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. CLINICAL GUIDELINE FOR THE MANAGEMENT OF BARRETT S OESOPHAGUS Summary. Page 1 of 12 Recurrent LGD at any point- discuss at MDT And consider RFA Patients with LGD should have a repeat endoscopy in 6 months.

More information

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN

SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN SHARED CARE GUIDELINE FOR BUCCAL MIDAZOLAM FOR THE TREATMENT OF PROLONGED SEIZURES IN CHILDREN 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the

More information

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0

METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 METABOLIC BONE DISEASE OF PREMATURITY NEONATAL CLINICAL GUIDELINE V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline To provide guidance on the prevention of metabolic bone disease in the neonate. All

More information

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate.

1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of acamprosate. SHARED CARE GUIDELINE FOR ACAMPROSATE 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients)

CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) CLINICAL GUIDELINE FOR MANAGEMENT OF NEUTROPENIC SEPSIS IN ADULT CANCER PATIENTS (this guideline excludes haematology patients) 1. Aim/Purpose of this Guideline 1.1. Systemic cancer treatments and immunological

More information

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE

GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE GESTATIONAL DIABETES MELLITUS AND SUBSEQUENT MANAGEMENT OF CONFIRMED GESTATIONAL DIABETES MELLITUS (GDM) AND SELECTIVE SCREENING - CLINICAL GUIDELINE V 1.5 2017 Screening - Clinical Guideline Page 1 of

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS

CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS CLINICAL GUIDELINE FOR MANAGEMENT OF GALLSTONES PATHOLOGY IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of gallstones pathology in adults. It has been benchmarked against

More information

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0

Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation Clinical Guideline V5.0 Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia or Intravenous Sedation November 2018 Summary. Fasting for Adults (including Young Adults Age 16+ years) who require Anaesthesia

More information

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR INTRAVENOUS FLUID THERAPY FOR ADULTS IN HOSPITAL 1. Aim/Purpose of this Guideline 1.1. This guideline contains recommendations about general principles for managing intravenous (IV)

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOKALAEMIA POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3.

Start. What is the serum phosphate concentration? Moderate Hypophosphataemia mmol/l. Replace using oral. phosphate. (See section 3. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPOPHOSPHATAEMIA IN ADULTS Summary. Key: General Notes GP/SWASFT ED/MAU/SRU/Acute GP/Amb-Care In-patient wards Start What is the serum concentration? Mild Hypophosphataemia

More information

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0

PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0 PRESEPTAL AND ORBITAL CELLULITIS IN CHILDREN- CLINICAL GUIDELINE V3.0 Page 1 of 8 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical and nursing staff caring for a child with Preseptal

More information

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall

Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall Clinical guideline for the introduction of Sacubitril Valsartan in primary and secondary care in Cornwall Page 1 of 15 Summary Patient clinically assessed and reviewed by a Consultant Cardiologist, Cardiology

More information

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance

SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline. 2. The Guidance SHARED CARE GUIDELINE FOR MODAFINIL 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate prescription and administration of modafinil.

More information

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR USE OF A PATIENT CONTROLLED ANALGESIA OR INTRAVENOUS OPIATE INFUSION IN CHILD HEALTH. 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled Analgesia

More information

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE

MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE MANAGEMENT OF NEONATAL HYPOTENSION CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the assessment and management of infants with hypotension. All involved will benefit from

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4. CLINICAL GUIDELINE FOR THE MANAGEMENT OF HIGH BLOOD GLUCOSE LEVELS AND SICK DAYS FOR INSULIN PUMP USERS UNDER THE PAEDIATRIC DIABETES SERVICE. V4.1 Page 1 of 11 1. Aim/Purpose of this Guideline 1.1. The

More information

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018

Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018 Patient Controlled Analgesia/Intravenous Opiate Infusion in Child Health Clinical Guideline V4.0 October 2018 Page 1 of 12 1. Aim/Purpose of this Guideline Guideline for children with a Patient Controlled

More information

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline SHARED CARE GUIDELINE FOR RIFAXIMIN FOR PREVENTING EPISODES OF OVERT HEPATIC ENCEPHALOPATHY IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy

More information

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18

Suspected Pulmonary embolus Ambulatory Pathway. Document Title. Date Issued/Approved: Date Valid From: 11/11/17. Date Valid To: 11/05/18 POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAIS IN INFANTS AND CHILDREN UNDER SITEEN YEARS OF AGE V3.0 Page 1 of 16 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide

More information

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0

Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0 Captopril and Enalapril (Ace Inhibitor) Therapy Clinical Guideline V1.0 November 2018 Summary Prescribing, monitoring and administration of Captopril and Enalapril FOR STAFF PATIENTS Medical and Nursing

More information

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline

CLINICAL PROCEDURE FOR THE SAFE REMOVAL OF FEMORAL ARTERIAL SHEATHS USING A DIGITAL APPROACH 1. Aim/Purpose of this Guideline POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0

CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0 CLINICAL GUIDELINE FOR NEONATAL BCG VACCINATION V3.0 Page 1 of 11 1. Aim/Purpose of this Guideline 1.1. Tuberculosis is a notifiable disease in the UK and although incidence is low it remains a Public

More information

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018

Hypoglycaemia in Adults with Diabetes Clinical Guideline V5.0. March 2018 March 2018 Page 1 of 11 Adult with Diabetes and blood glucose < 4 mmol/l Treatment as per Guideline: Nursing / Clinical Staff Patient reviewed as per guideline guidance notes: Nursing / Clinical Staff

More information

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR AN EPIDURAL INFUSION IN CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide guidance on caring for children who are receiving epidural

More information

Bladder care postpartum including bladder care for women with epidural analgesia (GL792)

Bladder care postpartum including bladder care for women with epidural analgesia (GL792) Bladder care postpartum including bladder care for women with epidural analgesia (GL792) Approval Approval Group Job Title, Chair of Committee Date Maternity & Children's Services Clinical Governance Committee

More information

PROTOCOL FOR BLADDER CARE MANAGEMENT DURING INTRAPARTUM AND POSTNATAL PERIOD

PROTOCOL FOR BLADDER CARE MANAGEMENT DURING INTRAPARTUM AND POSTNATAL PERIOD PROTOCOL FOR BLADDER CARE MANAGEMENT DURING INTRAPARTUM AND POSTNATAL PERIOD Specialty: Obstetrics Date Approved: Revised September 2015 Approved by: Labour Ward Forum Date for Review: September 2018 Overview

More information

Injection of Urethral Bulking Agents

Injection of Urethral Bulking Agents Injection of Urethral Bulking Agents Department of Gynaecology Patient Information What are urethral bulking agents? Urethral bulking agents are substances that are injected to support the bladder neck.

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic?

CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary. Start. End. Key: Na + below normal range ( mmol/L) Symptomatic? CLINICAL GUIDELINE FOR THE MANAGEMENT OF HYPONATRAEMIA Summary Key: General tes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Na + below normal range (135 145mmol/L) Refer to endocrinology

More information

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4

DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4 DIABETES IN PREGNANCY, TYPE 1 AND TYPE 2 DIABETES MELLITUS (DM), CLINICAL GUIDELINE FOR MIDWIVES V1.4 1 1. Aim/Purpose of this Guideline To provide guidance to Midwives, Obstetricians and the Joint Obstetric/Diabetes

More information

CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS

CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS CLINICAL GUIDELINE FOR MANAGEMENT OF ACUTE CHOLECYSTITIS IN ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of acute cholecystitis in adults. It has been benchmarked against

More information

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0

Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 Procedure for Subcutaneous Injection of Insulin or GLP1 Analogue in Adults Using a Pen Device V2.0 11 October 2017 Table of Contents 1. Introduction.. 3 2. Purpose of this Policy/Procedure. 3 3. Scope

More information

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019

Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019 Pelvic Inflammatory Disease Clinical Guideline V1.0 February 2019 Summary This guideline will provide evidence based guidance on the management of Pelvic Inflammatory Disease A low threshold for empirical

More information

Patient Urinary Catheter Passport

Patient Urinary Catheter Passport Useful contact details Name Contact Number Produced by Adapted from Worth by Michelle Pickering, Continence Specialist Practitioner Hambleton and Richmondshire Locality Continence Advisory Service and

More information

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018

Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018 Prevention and Treatment of Mucositis in Children and Young People with Cancer Clinical Guideline V3.1 December 2018 1. Aim/Purpose of this Guideline This guideline applies to all medical and nursing staff

More information

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY

CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY This applies to adult patients only CLINICAL GUIDELINE FOR THE USE OF PHENYTOIN IN EPILEPSY Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Yes Patient already taking phenytoin?

More information

Post operative voiding dysfunction and the Value of Urodynamics. Dr Salwan Al-Salihi Urogynaecologist Obstetrician and Gynaecologist

Post operative voiding dysfunction and the Value of Urodynamics. Dr Salwan Al-Salihi Urogynaecologist Obstetrician and Gynaecologist Post operative voiding dysfunction and the Value of Urodynamics Dr Salwan Al-Salihi Urogynaecologist Obstetrician and Gynaecologist Learning objectives: v Pathophysiology of post op voiding dysfunction.

More information

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone)

Osteoblasts (cells which form new bone) Osteoclasts (cells which break down old bone) Clinical guideline for the administration of Bisphosphonates and other drugs affecting bone metabolism in Haematology and Oncology patients 1. Aim/Purpose of this Guideline 1.1. To provide education to

More information

Intermittent self-catheterisation (ISC) Information for patients Spinal Injuries

Intermittent self-catheterisation (ISC) Information for patients Spinal Injuries Intermittent self-catheterisation (ISC) Information for patients Spinal Injuries page 2 of 12 What is clean intermittent self-catheterisation (CISC)? Urinary catheterisation is a procedure used to drain

More information

Laser vaporisation of prostate (Green light laser prostate surgery): procedure-specific information

Laser vaporisation of prostate (Green light laser prostate surgery): procedure-specific information PATIENT INFORMATION Laser vaporisation of prostate (Green light laser prostate surgery): procedure-specific information What is the evidence base for this information? This leaflet includes advice from

More information

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR TREATMENT OF DEMENTIA 1. Aim/Purpose of this Guideline POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department

More information

INTRAPARTUM AND POSTNATAL BLADDER CARE

INTRAPARTUM AND POSTNATAL BLADDER CARE INTRAPARTUM AND POSTNATAL BLADDER CARE BACKGROUND Urinary retention is uncommon but carries significant morbidity and the risk is increased by a number of factors including epidural analgesia (Teo, et

More information

Transperineal ultrasound-guided biopsy of the prostate gland

Transperineal ultrasound-guided biopsy of the prostate gland PLEASE PRINT WHOLE FORM DOUBLE SIDED ON YELLOW PAPER Patient Information to be retained by patient biopsy of the prostate gland affix patient label What is a transperineal (TP) ultrasound-guided prostate

More information

Bladder Management Protocol Gynaecology

Bladder Management Protocol Gynaecology Bladder Management Protocol Gynaecology Aims To ensure that the female urinary bladder is appropriately managed both pre and post operatively. Catheters Urethral catheters are hollow tubes which are inserted

More information

Urinary Catheter Passport

Urinary Catheter Passport Urinary Catheter Passport Catheter Change Record and Looking After Your Urinary Catheter Please take this booklet with you if you are admitted to hospital or have an appointment Patient details Name Address

More information

INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY

INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY COVERING INCONTINENCE BE ON JUST NAPPIES CATHETERS TYPES AVAILABLE AND WHEN TO USE THEM JJ STENTS???

More information

Urinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition

Urinary Catheter Passport SAMPLE COPY. A guide to looking after a urinary catheter. (for service users and healthcare workers) 2nd Edition Urinary Catheter Passport A guide to looking after a urinary catheter (for service users and healthcare workers) 2nd Edition Contact details Urinary Catheter Passport Service user Name Address Postcode

More information

Bladder neck bulking injection. Information for patients Gynaecology

Bladder neck bulking injection. Information for patients Gynaecology Bladder neck bulking injection Information for patients Gynaecology What is a bladder neck bulking agent? It is a treatment option for stress urinary incontinence in women. What are the benefits of this

More information

Bladder neck incision: procedure-specific information

Bladder neck incision: procedure-specific information PATIENT INFORMATION Bladder neck incision: procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association of

More information

Patient Urinary Catheter Passport

Patient Urinary Catheter Passport Useful contact details: Continence Service (Community) 01724 298325 Continence Service (Goole) 01482 336951 Continence Service (SGH) 01724 282282 Ext 2823 Continence Service (DPOW) 01472 874111 Infection

More information

NHS Urinary Catheter Passport

NHS Urinary Catheter Passport South Sefton Care Home Innovation Programme (CHIP) PROTOCOL 07:Urinary Catheter Passport NHS Urinary Catheter Passport Information for patients and carers The passport is a hand held patient document for

More information

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0

MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0 MUCOSITIS IN CHILDREN AND YOUNG PEOPLE WITH CANCER- CLINICAL GUIDELINE FOR PREVENTION AND TREATMENT V3.0 Page 1 of 10 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all medical and nursing

More information

Tension-free Vaginal Tape (TVT)

Tension-free Vaginal Tape (TVT) Page 1 of 7 Tension-free Vaginal Tape (TVT) Introduction This leaflet will provide you with basic information about the Tension--free Vaginal Tape (TVT) procedure. What is a TVT? TVT is an operation to

More information

1st stage neuromodulation test

1st stage neuromodulation test 1st stage neuromodulation test Information for patients Urology PROUD TO MAKE A DIFFERENCE SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST page 2 of 12 This leaflet is to give you some background information

More information

A Clinical Guideline for Bladder Care in Labour and Postnatally

A Clinical Guideline for Bladder Care in Labour and Postnatally For Use in: Maternity department By: Clinical staff caring for women during pregnancy, labour and postnatally For: Obstetric patients Division responsible for document: Division 3- Women and Children s

More information

Sacrospinous Vault Suspension

Sacrospinous Vault Suspension gynaecology program Pre- and Post-operative Instructions: Sacrospinous Vault Suspension Informed Consent As part of informed consent, your doctor will talk to you about: What will be done during the surgery

More information

Urodynamic Tests. Department of Gynaecology. Patient Information

Urodynamic Tests. Department of Gynaecology. Patient Information Urodynamic Tests Department of Gynaecology Patient Information What are urodynamic tests? Urodynamic tests assess the dynamic function of the lower urinary tract. The tests assess 3 functions; The ability

More information

Clean Intermittent Self-Catheterisation (CISC)

Clean Intermittent Self-Catheterisation (CISC) Saint Mary s Hospital & Trafford General Hospital Uro-gynaecology Service Information for Patients Clean Intermittent Self-Catheterisation (CISC) What is catheterisation? Catheterisation involves passing

More information

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0

CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0 CLINICAL GUIDELINE FOR THE EVALUATION OF A CHILD PRESENTING WITH FEVER AND SEIZURE V3.0 Clinical Guideline Template Page 1 of 18 Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies

More information

Caring for your indwelling urinary catheter

Caring for your indwelling urinary catheter Caring for your indwelling urinary catheter Information for patients This information is produced by the Continence, Urology and Colorectal Service Leeds Community Healthcare NHS Trust Having a urinary

More information

Indwelling Urinary Catheters And Drainage systems

Indwelling Urinary Catheters And Drainage systems If you require this leaflet in any other format, e.g., large print, please telephone 01935 384256 Indwelling Urinary Catheters And Drainage systems Useful organisations Ms Society Helpline Tel: 0808 800

More information

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation

Clinical Guideline for the Management of Pot Operative Atrial Fibrillation Clinical Guideline for the Management of Pot Operative Atrial Fibrillation 1. Aim/Purpose of this Guideline 1.1. Atrial Fibrillation is the most common cardiac arrhythmia with a prevalence of around 0.5%

More information

Burch Colposuspension

Burch Colposuspension Burch Colposuspension Department of Gynaecology Patient Information What is is botulinum Burch colposuspension? toxin A? The operation is intended to support the bladder neck, which is the area between

More information

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline

SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline SHARED CARE GUIDELINE FOR MYCOPHENOLATE MOFETIL FOR RHEUMATOLOGY INDICATIONS 1. Aim/Purpose of this Guideline 1.1. This guideline applies to medical, nursing and pharmacy staff in the safe and appropriate

More information

Suprapubic catheter insertion in the radiology department. Information for patients Urology

Suprapubic catheter insertion in the radiology department. Information for patients Urology Suprapubic catheter insertion in the radiology department Information for patients Urology page 2 of 8 What is a suprapubic catheter? A suprapubic catheter is an indwelling tube that drains the bladder

More information

Shropshire s Continence Advisory Service INDWELLING URINARY CATHETERS

Shropshire s Continence Advisory Service INDWELLING URINARY CATHETERS Shropshire s Continence Advisory Service INDWELLING URINARY CATHETERS Information for Patients and Carers F:\CONTINENCE\Acute Urianary Retention\04-12\005- Indwelling Urinary Cathter Leaflet - A4-13-02-09.doc

More information

Acutely Painful testes

Acutely Painful testes 2.0 FINAL Guideline adopted from the Bedside Clinical Guideline Partnership EQUALITY IMPACT The Trust strives to ensure equality of opportunity for all both as a major employer and as a provider of health

More information

Sacrocolpopexy. Department of Gynaecology. Patient Information

Sacrocolpopexy. Department of Gynaecology. Patient Information Sacrocolpopexy Department of Gynaecology 2 Patient Information What What is is a a sacrocolpopexy? This is an operation carried out to correct prolapse of the vaginal vault in patients who had a hysterectomy.

More information

University College Hospital. Discharge information for patients after HIFU (High Intensity Focused Ultrasound) Urology Directorate

University College Hospital. Discharge information for patients after HIFU (High Intensity Focused Ultrasound) Urology Directorate University College Hospital Discharge information for patients after HIFU (High Intensity Focused Ultrasound) Urology Directorate 2 If you would like this document in another language or format, or require

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF CONVULSIVE STATUS EPILEPTICUS IN CHILDHOOD V3.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing

More information

Painful Bladder Syndrome/Interstitial Cystitis

Painful Bladder Syndrome/Interstitial Cystitis n The Leeds Teaching Hospitals NHS Trust Painful Bladder Syndrome/Interstitial Cystitis Information for patients Leeds Centre for Women s Health Welcome to the Department of Urogynaecology Your consultant

More information

Transurethral Resection of the Prostate (TURP)

Transurethral Resection of the Prostate (TURP) Transurethral Resection of the Prostate (TURP) UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm Introduction

More information

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0

CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0 CLINICAL GUIDELINE FOR THE MANAGEMENT OF VIRAL LARYNGO-TRACHEOBRONCHITIS (CROUP) V3.0 Clinical Guideline Template Page 1 of 13 1. Aim/Purpose of this Guideline 1.1. This guideline applies to all nursing

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Pre-filled Patient Controlled Analgesia (PCA) syringes The Newcastle upon Tyne Hospitals NHS Foundation Trust Pre-filled Patient Controlled Analgesia (PCA) syringes Version.: 2.2 Effective From: 1 June 2016 Expiry Date: 1 June 2019 Date Ratified: 20 April

More information

Bladder tumour resection (TURBT): procedure-specific information

Bladder tumour resection (TURBT): procedure-specific information PATIENT INFORMATION Bladder tumour resection (TURBT): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association

More information

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents

Melatonin shared care guideline. Document Title. Corporate: Clinical. Type of document. Brief summary of contents Document Title Melatonin shared care guideline Type of document Corporate: Clinical Brief summary of contents Executive Director responsible for Policy: Directorate / Department responsible (author/owner):

More information

Managing your bladder with a Supra-pubic catheter at home

Managing your bladder with a Supra-pubic catheter at home Managing your bladder with a Supra-pubic catheter at home Providing a range of NHS services in Gateshead, South Tyneside and Sunderland. Managing your bladder with a Supra-pubic catheter at home The purpose

More information

Ambulatory Emergency Care Pathways. Acute Painful Bladder Outflow Obstruction

Ambulatory Emergency Care Pathways. Acute Painful Bladder Outflow Obstruction Ambulatory Emergency Care Pathways Acute Painful Bladder Outflow Obstruction Effective Date: November 2011 Content Summary Ref Title Description 1 Condition Details Identifies pathway details and clinical

More information

Transurethral Resection of Prostate (TURP)

Transurethral Resection of Prostate (TURP) Transurethral Resection of Prostate (TURP) This leaflet explains: What does the procedure involve?... 2 What are the alternatives to this procedure?... 2 What should I expect before the procedure?... 2

More information

Families Unit Division

Families Unit Division Families Unit Division Sub-Urethral Tape Procedure Operations Patient Information Leaflet Options available If you d like a large print, audio, Braille or a translated version of this leaflet then please

More information

What is a TURBT? Removal of an abnormal area within the bladder which may, or may not, prove to be cancer.

What is a TURBT? Removal of an abnormal area within the bladder which may, or may not, prove to be cancer. What is a TURBT? Removal of an abnormal area within the bladder which may, or may not, prove to be cancer. What are the benefits of this operation? Removal of an abnormality which is sent for analysis

More information

Transurethral Resection of Prostate

Transurethral Resection of Prostate Transurethral Resection of Prostate Information for Patients This leaflet explains: What does the procedure involve?...2 What are the alternatives to this procedure?...2 What should I expect before the

More information

Transurethral Prostatectomy (TURP) for Benign Disease

Transurethral Prostatectomy (TURP) for Benign Disease Transurethral Prostatectomy (TURP) for Benign Disease Whiston Hospital Warrington Road, Prescot, Merseyside, L35 5DR Telephone: 0151 426 1600 St Helens Hospital Marshall Cross Road, St Helens, Merseyside,

More information

Percutaneous nephrolithotomy (PCNL)

Percutaneous nephrolithotomy (PCNL) Percutaneous nephrolithotomy (PCNL) Department of Urology Patient Information What What is a is percutaneous a percutaneous nephrolithotomy nephrolithotomy (PCNL)? (PCNL)? A percutaneous nephrolithotomy

More information

Patient Information Leaflet

Patient Information Leaflet Patient Information Leaflet MID-URETHRAL SLING OPERATION TENSION-FREE VAGINAL TAPE (TVT) TRANSOBTURATOR TAPE (TOT, TVT-O) This information leaflet has been developed to help your understanding of what

More information

PLEASE TAKE THIS BOOKLET WITH YOU TO ALL HEALTHCARE APPOINTMENTS AND ON ADMISSION TO HOSPITAL

PLEASE TAKE THIS BOOKLET WITH YOU TO ALL HEALTHCARE APPOINTMENTS AND ON ADMISSION TO HOSPITAL Patient Urinary Passport Royal Devon and Exeter NHS Foundation Trust Patient Information Patient Urinary Passport Looking After Your This is a patient held record PLEASE TAKE THIS BOOKLET WITH YOU TO ALL

More information

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018

The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline V5.0 December 2018 The Management of Children and Young People with Newly Presenting Diabetes Clinical Guideline December 2018 Summary GP suspects diabetes Under 16 years or still in School Year 11 NO Refer Adults YES Section

More information

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist Lower Urinary Tract Symptoms Storage Symptoms Frequency, urgency, incontinence, Nocturia Voiding Symptoms Hesitancy, poor flow, intermittency,

More information

Vesico-Vaginal Fistula

Vesico-Vaginal Fistula Information for Patients Vesico-Vaginal Fistula Saint Mary s Hospital/Trafford General Hospiatl Uro-gynaecology Service What is a vesico-vaginal fistula? A vesico-vaginal fistula is an abnormal connection

More information